COARTEM

This brand name is authorized in United States, South Africa

Active ingredients

The drug COARTEM contains a combination of these active pharmaceutical ingredients (APIs):

1 Artemether UNII C7D6T3H22J - ARTEMETHER

Artemether is an antimalarial agent used to treat acute uncomplicated malaria. It is administered in combination with lumefantrine for improved efficacy. This combination therapy exerts its effects against the erythrocytic stages of Plasmodium spp. and may be used to treat infections caused by P. falciparum and unidentified Plasmodium species, including infections acquired in chloroquine-resistant areas. Read about Artemether

2 Lumefantrine UNII F38R0JR742 - LUMEFANTRINE

Read about Lumefantrine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
COARTEM Tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
P01BF01	Artemether and lumefantrine	P Antiparasitic products, insecticides and repellents → P01 Antiprotozoals → P01B Antimalarials → P01BF Artemisinin and derivatives, combinations
Discover more medicines within P01BF01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: US	FDA, National Drug Code	Identifier(s): 0078-0568
Country: ZA	Health Products Regulatory Authority	Identifier(s): 34/20.2.6/0161, 43/20.2.6/0225